ARALEZ PHARMACEUTICALS INC. Interest Expense
ARALEZ PHARMACEUTICALS INC. reported Interest Expense of $6.66 million for the 3-month period ending 2018-03-31, per its 10-Q filed 2018-05-08.
Discontinued › Expense Statement
us-gaap:InterestExpense · last filed 2018-05-08
- ARALEZ PHARMACEUTICALS INC. interest expense for the quarter ending 2018-03-31 was $6.66M, a 0.08% increase year-over-year.
- ARALEZ PHARMACEUTICALS INC. interest expense for the quarter ending 2017-12-31 was $6.80M, a 43.30% increase year-over-year.
- ARALEZ PHARMACEUTICALS INC. interest expense for the quarter ending 2017-09-30 was $6.80M, a 1274.34% increase year-over-year.
- ARALEZ PHARMACEUTICALS INC. interest expense for the quarter ending 2017-06-30 was $6.73M, a 1034.40% increase year-over-year.
- ARALEZ PHARMACEUTICALS INC. interest expense for fiscal 2017 was $26.98M, a 339.41% increase from fiscal 2016.
- ARALEZ PHARMACEUTICALS INC. interest expense for fiscal 2016 was $6.14M.
| Period end | Interest Expense 3 month | Interest Expense 6 month | Interest Expense 9 month | Interest Expense 12 month |
|---|---|---|---|---|
| 2018-03-31 | $6.66M 10-Q · filed 2018-05-08 | $13.46M derived: sum of 2 quarters · filed 2018-05-08 | $20.26M derived: sum of 3 quarters · filed 2018-05-08 | $26.99M derived: sum of 4 quarters · filed 2018-05-08 |
| 2017-12-31 | $6.80M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-14 | $13.60M derived: sum of 2 quarters · filed 2018-03-14 | $20.33M derived: sum of 3 quarters · filed 2018-03-14 | $26.98M 10-K · filed 2018-03-14 |
| 2017-09-30 | $6.80M 10-Q · filed 2017-11-09 | $13.53M derived: sum of 2 quarters · filed 2017-11-09 | $20.18M 10-Q · filed 2017-11-09 | $24.93M derived: sum of 4 quarters · filed 2018-05-08 |
| 2017-06-30 | $6.73M 10-Q · filed 2017-08-09 | $13.38M 10-Q · filed 2017-08-09 | $18.13M derived: sum of 3 quarters · filed 2018-05-08 | $18.62M derived: sum of 4 quarters · filed 2018-05-08 |
| 2017-03-31 | $6.65M 10-Q · filed 2018-05-08 | $11.40M derived: sum of 2 quarters · filed 2018-05-08 | $11.89M derived: sum of 3 quarters · filed 2018-05-08 | $12.49M derived: sum of 4 quarters · filed 2018-05-08 |
| 2016-12-31 | $4.75M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-14 | $5.24M derived: sum of 2 quarters · filed 2018-03-14 | $5.83M derived: sum of 3 quarters · filed 2018-03-14 | $6.14M 10-K · filed 2018-03-14 |
| 2016-09-30 | $495.00K 10-Q · filed 2017-11-09 | $1.09M derived: sum of 2 quarters · filed 2017-11-09 | $1.40M 10-Q · filed 2017-11-09 | |
| 2016-06-30 | $593.00K 10-Q · filed 2017-08-09 | $900.00K 10-Q · filed 2017-08-09 |